What are the major opportunities in the Dengvaxia market? What are the strategies for the Dengvaxia market?

For detailed insights on the major opportunities and strategies in the Dengvaxia market, Read More

How does the Dengvaxia market relate to the overall economy and other similar markets?

For detailed insights on Dengvaxia's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Dengvaxia industry?

For detailed insights on the mergers and acquisitions in the Dengvaxia industry, Read More

What are the key dynamics influencing the Dengvaxia market growth? SWOT analysis of the Dengvaxia market.

For detailed insights on the key dynamics influencing the Dengvaxia market growth and SWOT analysis of the Dengvaxia industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Dengvaxia Global Market Report 2025

Name: Dengvaxia Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Dengvaxia, Other Types), By Distribution Channel (Hospitals, Clinics, Public Health Programs), By Clinical Indication (Prevention In Previously Infected Individuals, Protection In High-Risk Regions, Traveler Immunization, Pediatric And Adolescent Use)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Dengvaxia Market?

Dengvaxia is a recombinant vaccine developed to protect against dengue fever, a viral illness transmitted by Aedes mosquitoes, by stimulating the immune system to produce a targeted response that helps prevent infection and severe complications, contributing to public health efforts in regions where dengue is endemic.

The main types of dengvaxia are dengvaxia and others. Dengvaxia is a specific vaccine developed to prevent dengue fever. It is the first dengue vaccine approved for use and is designed to provide immunity against the virus that causes dengue. It helps reduce the severity and frequency of dengue episodes, making it an important tool in areas prone to dengue outbreaks. Dengvaxia has been used in various countries where dengue is prevalent to protect high-risk populations. These are distributed through hospitals, clinics, and public health programs and are used in multiple clinical indications such as prevention in previously infected individuals, protection in high-risk regions, traveler immunization, and pediatric and adolescent use.

Dengvaxia Market Size and growth rate 2025 to 2029: Graph

What Is The Dengvaxia Market Size 2025 And Growth Rate?

The dengvaxia market size has grown rapidly in recent years. It will grow from $181.23 million in 2024 to $213.36 million in 2025 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to government health initiatives, growing public health awareness, the need for preventive measures, rising travel-related dengue cases, and improved healthcare infrastructure.

What Is The Dengvaxia Market Growth Forecast?

The dengvaxia market size is expected to see rapid growth in the next few years. It will grow to $404.70 million in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to rising incidence of dengue outbreaks, increased government funding, collaboration between public and private sectors, growing public awareness of dengue prevention, and enhanced healthcare infrastructure. Major trends in the forecast period include advancements in vaccine technology, ongoing research and development, innovations in vaccine delivery methods, development of new formulations, and better vaccine storage and distribution techniques.

Book your 30 minutes free consultation with our research experts

How Is The Dengvaxia Market Segmented?

The dengvaxia market covered in this report is segmented –

1) By Type: Dengvaxia, Other Types

2) By Distribution Channel: Hospitals, Clinics, Public Health Programs

3) By Clinical Indication: Prevention In Previously Infected Individuals, Protection In High-Risk Regions, Traveler Immunization, Pediatric And Adolescent Use

What Is Driving The Dengvaxia Market? Rising Dengue Incidence Drives Growth In The Market

The high incidence of dengue is expected to propel the growth of the dengvaxia market going forward. Dengue is a viral infection transmitted by Aedes mosquitoes, causing flu-like symptoms, severe pain, and in severe cases, potentially life-threatening complications such as dengue hemorrhagic fever or dengue shock syndrome. The increasing prevalence of dengue is due to climate change, urbanization, increased travel, and expanding mosquito breeding grounds, leading to higher infection rates and greater demand for prevention and treatment. Dengvaxia helps prevent dengue as it is an effective vaccine that stimulates the immune system to produce a protective response against the dengue virus, reducing the risk of infection and severe complications and contributing to better public health outcomes in endemic areas. For instance, in June 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, in 2024 the Americas reported over 9.7 million dengue cases, double the 4.6 million cases in 2023. Puerto Rico declared a public health emergency with 1,498 cases, and 745 cases were reported among U.S. travelers. Therefore, the high incidence of dengue is driving growth in the dengvaxia market.

What Is Driving The Dengvaxia Market? Impact Of Rising International Travel On Market Growth

Rising international travel is expected to propel the growth of the dengvaxia market going forward. International travel refers to the act of traveling between different countries for purposes such as tourism, business, or education. Rising international travel increases the risk of spreading infectious diseases, including dengue, which drives the demand for preventive measures like vaccines. Dengvaxia is used in rising international travel to protect travelers from contracting dengue in endemic regions and reduce the risk of disease transmission across borders. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, in 2023, the number of international visits to the UK saw a significant increase, rising from 31.2 million in 2022 to 38.0 million. Therefore, rising international travel will drive the growth of the dengvaxia market.

What Is Driving The Dengvaxia Market? Impact Of Growing Healthcare Expenditures On Market Expansion

Growing healthcare expenditures are expected to accelerate the growth of the dengvaxia market going forward. Healthcare expenditures refer to the financial resources allocated by governments, private entities, or individuals for the provision of healthcare services, medical treatments, and health-related activities. Growth in healthcare expenditures is driven by the increasing demand for medical services, advancements in healthcare technology, and the rising prevalence of chronic diseases, which leads to greater investment in healthcare infrastructure and treatments. Healthcare expenditure on Dengvaxia focuses on prevention, aiming to reduce the long-term costs of treating dengue and managing outbreaks. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, growing healthcare expenditures will drive the growth of the dengvaxia market.

Who Are The Major Players In The Global Dengvaxia Market?

Major companies operating in the dengvaxia market include Sanofi Pasteur Inc.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Dengvaxia Market

Asia-Pacific was the largest region in the dengvaxia market in 2024. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the dengvaxia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dengvaxia market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Dengvaxia Market?

The dengvaxia market consists of sales of dengvaxia (CYD-TDV), disposable syringes and needles, pre-filled syringes of dengvaxia, and unit-dose packaging. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Dengvaxia Industry?

The dengvaxia market research report is one of a series of new reports from The Business Research Company that provides dengvaxia market statistics, including dengvaxia industry global market size, regional shares, competitors with a dengvaxia market share, detailed dengvaxia market segments, market trends and opportunities, and any further data you may need to thrive in the dengvaxia industry. This dengvaxia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dengvaxia Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Dengvaxia, Other Types 2) By Distribution Channel: Hospitals, Clinics, Public Health Programs 3) By Clinical Indication: Prevention In Previously Infected Individuals, Protection In High-Risk Regions, Traveler Immunization, Pediatric And Adolescent Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sanofi Pasteur Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Dengvaxia Market Characteristics

3. Dengvaxia Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Dengvaxia Market Trends And Strategies

5. Dengvaxia Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Dengvaxia Growth Analysis And Strategic Analysis Framework

6.1. Global Dengvaxia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Dengvaxia Market Growth Rate Analysis

6.4. Global Dengvaxia Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Dengvaxia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Dengvaxia Total Addressable Market (TAM)

7. Global Dengvaxia Pricing Analysis & Forecasts

8. Dengvaxia Market Segmentation

8.1. Global Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Dengvaxia

Other Types

8.2. Global Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Clinics

Public Health Programs

8.3. Global Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Prevention In Previously Infected Individuals

Protection In High-Risk Regions

Traveler Immunization

Pediatric And Adolescent Use

9. Global Dengvaxia Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Dengvaxia Market Regional And Country Analysis

10.1. Global Dengvaxia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Dengvaxia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Dengvaxia Market

11.1. Asia-Pacific Dengvaxia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Dengvaxia Market

12.1. China Dengvaxia Market Overview

12.2. China Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Dengvaxia Market

13.1. India Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Dengvaxia Market

14.1. Japan Dengvaxia Market Overview

14.2. Japan Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Dengvaxia Market

15.1. Australia Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Dengvaxia Market

16.1. South Korea Dengvaxia Market Overview

16.2. South Korea Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Dengvaxia Market

17.1. Western Europe Dengvaxia Market Overview

17.2. Western Europe Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Dengvaxia Market

18.1. UK Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Dengvaxia Market

19.1. Germany Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Dengvaxia Market

20.1. France Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Dengvaxia Market

21.1. Eastern Europe Dengvaxia Market Overview

21.2. Eastern Europe Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Dengvaxia Market

22.1. North America Dengvaxia Market Overview

22.2. North America Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Dengvaxia Market

23.1. USA Dengvaxia Market Overview

23.2. USA Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Dengvaxia Market

24.1. Canada Dengvaxia Market Overview

24.2. Canada Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Dengvaxia Market

25.1. South America Dengvaxia Market Overview

25.2. South America Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Dengvaxia Market

26.1. Middle East Dengvaxia Market Overview

26.2. Middle East Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Dengvaxia Market

27.1. Africa Dengvaxia Market Overview

27.2. Africa Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Dengvaxia Market Competitive Landscape And Company Profiles

28.1. Dengvaxia Market Competitive Landscape

28.2. Dengvaxia Market Company Profiles

28.2.1. Sanofi Pasteur Inc Overview, Products and Services, Strategy and Financial Analysis

29. Global Dengvaxia Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Dengvaxia Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Dengvaxia Market

32. Recent Developments In The Dengvaxia Market

33. Dengvaxia Market High Potential Countries, Segments and Strategies

33.1 Dengvaxia Market In 2029 - Countries Offering Most New Opportunities

33.2 Dengvaxia Market In 2029 - Segments Offering Most New Opportunities

33.3 Dengvaxia Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Dengvaxia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Dengvaxia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Sanofi Pasteur Inc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Dengvaxia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Dengvaxia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Dengvaxia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Dengvaxia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Dengvaxia Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Sanofi Pasteur Inc Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

Metabolic Disorders Drugs Global Market Report 2022 – By Type (Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)), By Distribution Channel (Hospital Pharmacies, Retai...

Frequently Asked Questions

What is the definition of the Dengvaxia market?

How will the Dengvaxia market drivers and restraints affect the market dynamics? What forces will shape the Dengvaxia industry going forward?

The Dengvaxia market major growth driver - Rising Dengue Incidence Drives Growth In The Market. For further insights on the Dengvaxia market, request a sample here

What is the forecast market size or the forecast market value of the Dengvaxia market?

The Dengvaxia market size has grown strongly in recent years. The dengvaxia market size has grown rapidly in recent years. It will grow from $181.23 million in 2024 to $213.36 million in 2025 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to government health initiatives, growing public health awareness, the need for preventive measures, rising travel-related dengue cases, and improved healthcare infrastructure. The dengvaxia market size is expected to see rapid growth in the next few years. It will grow to $404.70 million in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to rising incidence of dengue outbreaks, increased government funding, collaboration between public and private sectors, growing public awareness of dengue prevention, and enhanced healthcare infrastructure. Major trends in the forecast period include advancements in vaccine technology, ongoing research and development, innovations in vaccine delivery methods, development of new formulations, and better vaccine storage and distribution techniques. For further insights on the Dengvaxia market, request a sample here

How is the Dengvaxia market segmented?

The dengvaxia market covered in this report is segmented –
1) By Type: Dengvaxia, Other Types
2) By Distribution Channel: Hospitals, Clinics, Public Health Programs
3) By Clinical Indication: Prevention In Previously Infected Individuals, Protection In High-Risk Regions, Traveler Immunization, Pediatric And Adolescent Use For further insights on the Dengvaxia market, request a sample here

Which region has the largest share of the Dengvaxia market? What are the other regions covered in the report?

Who are the major players in the Dengvaxia market?

Major companies operating in the dengvaxia market include Sanofi Pasteur Inc. . For further insights on the Dengvaxia market, request a sample here.

What are the key trends in the Dengvaxia market?

Major trends in the Dengvaxia market include . For further insights on the Dengvaxia market, request a sample here.